Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Maintenance therapy of persons with schizophrenia.

Carpenter WT Jr.

J Clin Psychiatry. 1996;57 Suppl 9:10-8. Review.

PMID:
8823345
2.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

Early, targeted pharmacotherapeutic intervention in schizophrenia.

Carpenter W Jr.

J Clin Psychiatry. 1986 May;47 Suppl:23-9. Review.

PMID:
2871012
5.

A program for relapse prevention in schizophrenia: a controlled study.

Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G.

Arch Gen Psychiatry. 2000 Mar;57(3):277-83.

PMID:
10711914
6.

Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.

Shriqui CL.

Can J Psychiatry. 1995 Sep;40(7 Suppl 2):S38-48. Review.

PMID:
8564916
7.

Clinical experience in developing treatment regimens with the novel antipsychotic risperidone.

Kopala LC.

Int Clin Psychopharmacol. 1997 Sep;12 Suppl 4:S11-8. Review.

PMID:
9352341
8.

Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.

Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG.

Arch Gen Psychiatry. 1997 May;54(5):453-63.

PMID:
9152099
9.

Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.

Schooler NR, Keith SJ, Severe JB, Matthews SM.

Psychiatr Q. 1995 Winter;66(4):279-92. Review.

PMID:
8584586
10.

Management strategies for the treatment of schizophrenia.

Kane JM.

J Clin Psychiatry. 1999;60 Suppl 12:13-7. Review.

11.

Clozapine maintenance therapy in schizophrenia.

Gaszner P, Makkos Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):465-9.

PMID:
15093952
12.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia..

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
13.

Basic elements in biobehavioral treatment and rehabilitation of schizophrenia.

Liberman RP, Kopelowicz A.

Int Clin Psychopharmacol. 1995 Jan;9 Suppl 5:51-8. Review.

PMID:
7622835
14.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group..

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
15.

Early detection and intervention in schizophrenia.

Linszen DH, Dingemans PM, Lenior ME, Scholte WF, de Haan L, Goldstein MJ.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S31-4. Review.

PMID:
9690968
16.

Treatment of the neuroleptic-nonresponsive schizophrenic patient.

Meltzer HY.

Schizophr Bull. 1992;18(3):515-42. Review.

17.

The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.

Schooler NR.

J Clin Psychopharmacol. 1986 Feb;6(1 Suppl):11S-19S. Review.

PMID:
2870086
18.

Management of schizophrenia.

Marder SR.

J Clin Psychiatry. 1996;57 Suppl 3:9-13; discussion 47. Review.

PMID:
8626371
19.

Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia.

Wiedemann G, Hahlweg K, Müller U, Feinstein E, Hank G, Dose M.

Eur Arch Psychiatry Clin Neurosci. 2001;251(2):72-84.

PMID:
11407442
20.

Antipsychotic medication: clinical guidelines for maintenance therapy.

Johnson DA.

J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15. Review.

PMID:
2859281
Items per page

Supplemental Content

Support Center